293 Results for "

oral treatment

" in MedChemExpress (MCE) Product Catalog:
Products (293)

293 Results for "oral treatment" in MCE Product Catalog:

172
172 Publications Verification
Cat. No.: HY-13027
CAS No.: 208255-80-5
Purity:  99.97%
Synonyms: GSI-IX
DAPT (GSI-IX) is a potent and orally active γ-secretase inhibitor with IC50s of 115 nM and 200 nM for total amyloid-β (Aβ) and 42, respectively. DAPT inhibits the activation of Notch 1 signaling and induces cell differentiation. DAPT also induces autophagy and apoptosis. DAPT has neuroprotection activity and has the potential for autoimmune and lymphoproliferative diseases, degenerative disease and cancers treatment .
loading...
    loading...
70
70 Cited Publications
Cat. No.: HY-10585A
CAS No.: 1069-66-5
Purity:  98.14%
Synonyms: Sodium Valproate; VPA sodium; 2-Propylpentanoic acid sodium
Valproic acid (Sodium Valproate) sodium is an orally active HDAC inhibitor, with IC50 in the range of 0.5 and 2 mM, also inhibits HDAC1 (IC50, 400 μM), and induces proteasomal degradation of HDAC2. Valproic acid sodium activates Notch1 signaling and inhibits proliferation in small cell lung cancer (SCLC) cells. Valproic acid sodium is used in the treatment of epilepsy, bipolar disorder, metabolic disease, HIV infection and prevention of migraine headaches .
loading...
    loading...
29
29 Cited Publications
Cat. No.: HY-N0142
CAS No.: 60-82-2
Synonyms: NSC 407292; RJC 02792
Phloretin (NSC 407292; RJC 02792) is a flavonoid extracted from Malus pumila Mill.,has anti-inflammatory activities. Phloridzin is a specific,competitive and orally active inhibitor of sodium/glucose cotransporters in the intestine (SGLT1) and kidney (SGLT2). Phloretin inhibits Yeast-made GLUT1 as well as Human erythrocyte GLUT1 with IC50values of 49 μM and 61 μM,respectively .Phloretin has the potential for the treatment of rheumatoid arthritis (RA) and allergic airway inflammation .
loading...
    loading...
28
28 Cited Publications
Cat. No.: HY-114392
CAS No.: 66225-78-3
Purity:  99.75%
Target:  

FXR Autophagy

Research Areas:  

Metabolic Disease

Gly-β-MCA, a bile acid, is a potent, sable, intestine-selective and oral bioactive farnesoid X receptor (FXR) inhibitor that may be a candidate for the treatment of metabolic disorders .
loading...
    loading...
25
25 Cited Publications
Cat. No.: HY-18938
CAS No.: 1448428-04-3
Synonyms: GS-4997
Target:  

MAP3K Apoptosis

Research Areas:  

Cancer

Selonsertib (GS-4997), an orally bioavailable, selective apoptosis signal-regulating kinase 1 (ASK1) inhibitor with a pIC50 of 8.3, has been evaluated as an experimental treatment for diabetic nephropathy and kidney fibrosis.
loading...
    loading...
23
23 Cited Publications
Cat. No.: HY-66011A
CAS No.: 151096-09-2
Synonyms: BAY 12-8039 free base
Target:  

Bacterial Antibiotic

Research Areas:  

Infection Cancer

Moxifloxacin is an orally active 8-methoxyquinolone antimicrobial for use in the treatment of acute bacterial sinusitis, acute bacterial exacerbations of chronic bronchitis, and community-acquired pneumonia .
loading...
    loading...
23
23 Cited Publications
Cat. No.: HY-66011
CAS No.: 186826-86-8
Synonyms: BAY 12-8039
Target:  

Bacterial Antibiotic

Research Areas:  

Infection Cancer

Moxifloxacin Hydrochloride (BAY 12-8039) is an oral 8-methoxyquinolone antimicrobial for use in the treatment of acute bacterial sinusitis, acute bacterial exacerbations of chronic bronchitis, and community-acquired pneumonia .
loading...
    loading...
22
22 Cited Publications
Cat. No.: HY-12169
CAS No.: 154039-60-8
Purity:  99.81%
Synonyms: BB2516; TA2516
Target:  

MMP

Research Areas:  

Cancer

Marimastat (BB2516) is a broad spectrum and orally bioavailable inhibitor of MMPs, with potent activity against MMP-9 (IC50=3 nM), MMP-1 (IC50=5 nM), MMP-2 (IC50=6 nM), MMP-14 (IC50=9 nM) and MMP-7 (IC50=13 nM), used in the treatment of cancer. Marimastat (BB2516) is an angiogenesis and metastasis inhibitor, which limits the growth and production of blood vessels. As an antimetatstatic agent it prevents malignant cells from breaching the basement membranes .
loading...
    loading...
20
20 Cited Publications
Cat. No.: HY-17608
CAS No.: 960539-70-2
Synonyms: GSK1278863
Research Areas:  

Cardiovascular Disease

Daprodustat (GSK1278863) is an orally active hypoxia-inducible factor prolyl hydroxylase (HIF-PH) inhibitor being developed for the treatment of anemia associated with chronic kidney disease.
loading...
    loading...
20
20 Cited Publications
Cat. No.: HY-14779
CAS No.: 625115-55-1
Purity:  99.80%
Synonyms: BAY 632521
Target:  

Guanylate Cyclase

Research Areas:  

Cardiovascular Disease

Riociguat is an oral stimulator of soluble guanylate cyclase (sGC) used in the treatment of pulmonary hypertension.
loading...
    loading...
19
19 Cited Publications
Cat. No.: HY-10528
CAS No.: 254964-60-8
Purity:  99.94%
Synonyms: ABR-215050
Target:  

HDAC

Research Areas:  

Cancer

Tasquinimod is an oral antiangiogenic agent, which has the potential for castration-resistant prostate cancer treatment. Tasquinimod binds to the regulatory Zn 2+ binding domain of HDAC4 with Kd of 10-30 nM. Tasquinimod also is a S100A9 inhibitor .
loading...
    loading...
17
17 Cited Publications
Cat. No.: HY-70037A
CAS No.: 364782-34-3
Synonyms: AMG-073 hydrochloride
Cinacalcet hydrochloride (AMG-073 hydrochloride) is an orally active, allosteric agonist of Ca receptor (CaR), used for cardiovascular disease treatment.
loading...
    loading...
17
17 Cited Publications
Cat. No.: HY-50682
CAS No.: 603148-36-3
Synonyms: TTP488; PF-04494700
Target:  

Amyloid-β

Research Areas:  

Neurological Disease Cancer

Azeliragon (TTP488) is an orally bioavailable inhibitor of the receptor for advanced glycation end products (RAGE) in development as a potential treatment to slow disease progression with mild Alzheimer’s disease (AD) . Azeliragon also can cross the blood-brain barrier (BBB) .
loading...
    loading...
17
17 Cited Publications
Cat. No.: HY-100022
CAS No.: 1849590-01-7
Purity:  99.92%
Synonyms: eFT508
Target:  

MNK PD-1/PD-L1

Research Areas:  

Cancer

Tomivosertib (eFT508) is a potent, highly selective, and orally active MNK1 and MNK2 inhibitor, with IC50s of 1-2 nM against both isoforms. Tomivosertib (eFT508) treatment leads to a dose-dependent reduction in eIF4E phosphorylation at serine 209 (IC50=2-16 nM) in tumor cell lines . Tomivosertib (eFT508) also dramatically downregulates PD-L1 protein abundance .
loading...
    loading...
16
16 Cited Publications
Cat. No.: HY-135825
CAS No.: 39777-61-2
Purity:  99.71%
Target:  

Autophagy

Research Areas:  

Neurological Disease

TFEB activator 1 is an orally effective, mTOR-independent activator of TFEB. TFEB activator 1 significantly promotes the nuclear translocation of Flag-TFEB with an EC50 of 2167 nM. TFEB activator 1 enhances autophagy without inhibiting the mTOR pathway and has the potential for neurodegenerative diseases treatment .
loading...
    loading...
16
16 Cited Publications
Cat. No.: HY-125840
CAS No.: 1672668-24-4
Purity:  99.85%
Synonyms: PT2977; MK-6482
Research Areas:  

Cancer

Belzutifan (PT2977) is an orally active and selective HIF-2α inhibitor with an IC50 of 9 nM. Belzutifan, as a second-generation HIF-2α inhibitor, increases potency and improves pharmacokinetic profile. Belzutifan is a potential treatment for clear cell renal cell carcinoma (ccRCC) .
loading...
    loading...
13
13 Cited Publications
Cat. No.: HY-10064
CAS No.: 274693-27-5
Purity:  99.95%
Synonyms: AZD6140; AR-C 126532XX
Target:  

P2Y Receptor

Research Areas:  

Cardiovascular Disease Cancer

Ticagrelor (AZD6140) is a reversible oral P2Y12 receptor antagonist for the treatment of platelet aggregation.
loading...
    loading...
13
13 Cited Publications
Cat. No.: HY-50667
CAS No.: 503612-47-3
Synonyms: BMS-562247-01
Target:  

Factor Xa

Research Areas:  

Cardiovascular Disease Cancer

Apixaban (BMS-562247-01) is a highly selective, reversible and orally active inhibitor of Factor Xa with Ki of 0.08 nM and 0.17 nM in human and rabbit, respectively . Apixaban is in development for the prevention and treatment of various thromboembolic diseases .
loading...
    loading...
13
13 Cited Publications
Cat. No.: HY-16643
CAS No.: 1345982-69-5
Synonyms: GSK2330672
Linerixibat (GSK2330672) is a highly potent, nonabsorbable and orally active apical sodium-dependent bile acid transporter (ASBT) inhibitor with an IC50 of 42 nM human ASBT. Linerixibat can be used as lipid-lowering agent. Linerixibat has the potential for type 2 diabetes and Primary Biliary Cholangitis treatment .
loading...
    loading...
13
13 Cited Publications
Cat. No.: HY-A0014
CAS No.: 196597-26-9
Synonyms: TAK-375
Ramelteon is a potent, highly selective, and orally active agonist of MT1/MT2 with Ki values of 14 and 112 pM, respectively. Ramelteon has the potential for the research of insomnia. Ramelteon consistently reduces sleep onset after long-term treatment, with no next-morning residual effects or rebound insomnia or withdrawal symptoms upon discontinuation .
loading...
    loading...